12.43

2.48% 0.35

Delcath Systems Inc (DCTH)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Delcath Systems Inc stock is traded at $12.43, with a volume of 21,914. It is up +2.48% in the last 24 hours and down -23.96% over the past month. Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Previous Close:

$12.08

Open:

$12.16

24h Volume:

21,914

Relative Volume:

0.06

Market Cap:

$415.20M

Revenue:

$2.07M

Net Income/Loss:

$-47.68M

P/E Ratio:

-4.4078

EPS:

-2.82

Net Cash Flow:

$-31.31M

1W Performance:

-4.77%

1M Performance:

-23.96%

6M Performance:

+29.77%

1Y Performance:

+232.80%

1-Day Range:

$12.16

$12.52

1-Week Range:

$11.11

$13.00

52-Week Range:

$3.81

$16.97

Delcath Systems Inc Stock (DCTH) Company Profile

Name

Delcath Systems Inc

Sector

Healthcare (1171)

Industry

Medical Devices (159)

Phone

(518) 743-8892

Address

566 QUEENSBURY AVENUE, QUEENSBURY, NY

Employee

Twitter

@delcathsystems

Next Earnings Date

2024-11-08

Latest SEC Filings

DCTH's Discussions on Twitter

Compare DCTH with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DCTH Delcath Systems Inc	12.43	415.20M	2.07M	-47.68M	-31.31M	-2.82
ABT Abbott Laboratories	125.97	221.85B	41.95B	13.40B	6.35B	7.65
BSX Boston Scientific Corp	96.03	142.24B	16.75B	1.85B	2.37B	1.25
SYK Stryker Corp	368.83	140.07B	22.60B	2.99B	3.49B	7.76
MDT Medtronic Plc	92.96	118.98B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	68.34	40.31B	5.72B	4.17B	259.90M	6.97

Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-28-24	Initiated	Craig Hallum	Buy
May-14-24	Initiated	Stephens	Overweight
Jul-26-22	Resumed	Canaccord Genuity	Buy
Dec-10-21	Initiated	H.C. Wainwright	Buy
Mar-09-21	Initiated	Canaccord Genuity	Buy
Jan-05-21	Initiated	BTIG Research	Buy
Jun-01-20	Initiated	Laidlaw	Buy

View All

Delcath Systems Inc Stock (DCTH) Latest News

Mar 13, 2025

Delcath Systems Reports Strong 2024 Financial Growth - TipRanks

Mar 13, 2025

Mar 12, 2025

Delcath Systems, Inc. (NASDAQ:DCTH) Q4 2024 Earnings Call Transcript - MSN

Mar 12, 2025

Mar 11, 2025

With A 27% Price Drop For Delcath Systems, Inc. (NASDAQ:DCTH) You'll Still Get What You Pay For - Simply Wall St

Mar 11, 2025

Mar 10, 2025

Delcath Systems’ Earnings Call Highlights Strong Growth and Strategic Expansion - TipRanks

Mar 10, 2025

HC Wainwright Estimates Delcath Systems FY2029 Earnings - Defense World

Mar 10, 2025

Delcath Systems (NASDAQ:DCTH) Price Target Raised to $24.00 - Defense World

Mar 10, 2025

Mar 08, 2025

Earnings Beat: Delcath Systems, Inc. (NASDAQ:DCTH) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts - Yahoo Finance UK

Mar 08, 2025

Private Advisor Group LLC Acquires New Position in Delcath Systems, Inc. (NASDAQ:DCTH) - Defense World

Mar 08, 2025

Mar 07, 2025

Positive Outlook for Delcath Systems: Promising Growth and Strategic Expansion Drive Buy Rating - TipRanks

Mar 07, 2025

Delcath stock price target raised to $24 by H.C. Wainwright - Investing.com India

Mar 07, 2025

Strong Growth Potential for Delcath Systems: Buy Rating Affirmed with Raised Price Target - TipRanks

Mar 07, 2025

Delcath Systems reports net loss of USD 3.4M in Q4 2024 - Medical Buyer

Mar 07, 2025

Here's Why We're Not Too Worried About Delcath Systems' (NASDAQ:DCTH) Cash Burn Situation - Yahoo Finance

Mar 07, 2025